BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pape S, Schramm C, Gevers TJ. Clinical management of autoimmune hepatitis. United European Gastroenterol J 2019;7:1156-63. [PMID: 31700628 DOI: 10.1177/2050640619872408] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Domerecka W, Kowalska-Kępczyńska A, Michalak A, Homa-Mlak I, Mlak R, Cichoż-Lach H, Małecka-Massalska T. Etiopathogenesis and Diagnostic Strategies in Autoimmune Hepatitis. Diagnostics (Basel) 2021;11:1418. [PMID: 34441353 DOI: 10.3390/diagnostics11081418] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zannella A, Fanella S, Marignani M, Begini P. COVID-19 emergency: Changes in quality of life perception in patients with chronic liver disease-An Italian single-centre study. World J Hepatol 2022; 14(1): 274-286 [DOI: 10.4254/wjh.v14.i1.274] [Reference Citation Analysis]
3 Li SS, Niu M, Jing J, Huang Y, Zhang ZT, Chen SS, Shi GZ, He X, Zhang HZ, Xiao XH, Zou ZS, Yu YC, Wang JB. Metabolomic Signatures of Autoimmune Hepatitis in the Development of Cirrhosis. Front Med (Lausanne) 2021;8:644376. [PMID: 33777984 DOI: 10.3389/fmed.2021.644376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Fan T, Xie Y, Ma W. Research progress on the protection and detoxification of phytochemicals against aflatoxin B1-Induced liver toxicity. Toxicon 2021;195:58-68. [PMID: 33716068 DOI: 10.1016/j.toxicon.2021.03.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sirbe C, Simu G, Szabo I, Grama A, Pop TL. Pathogenesis of Autoimmune Hepatitis-Cellular and Molecular Mechanisms. Int J Mol Sci 2021;22:13578. [PMID: 34948375 DOI: 10.3390/ijms222413578] [Reference Citation Analysis]
6 van den Brand FF, Snijders RJALM, de Boer YS, Verwer BJ, van Nieuwkerk CMJ, Bloemena E, Kuiken SD, Drenth JPH, Bouma G. Drug withdrawal in patients with autoimmune hepatitis in long-term histological remission: A prospective observational study. Eur J Intern Med 2021;90:30-6. [PMID: 33865679 DOI: 10.1016/j.ejim.2021.03.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Kunovsky L, Dite P, Jabandziev P, Kala Z, Vaculova J, Andrasina T, Hrunka M, Bojkova M, Trna J. Autoimmune Diseases of Digestive Organs-A Multidisciplinary Challenge: A Focus on Hepatopancreatobiliary Manifestation. J Clin Med 2021;10:5796. [PMID: 34945093 DOI: 10.3390/jcm10245796] [Reference Citation Analysis]
8 Teles C, Santos R, Silva CD, Vaio T. Postinfantile giant cell hepatitis in the setting of autoimmune hepatitis: exclusively a histological pattern or a prognosis predictor? BMJ Case Rep 2021;14:e243660. [PMID: 34290027 DOI: 10.1136/bcr-2021-243660] [Reference Citation Analysis]
9 Pape S, Gevers TJG, Vrolijk JM, van Hoek B, Bouma G, van Nieuwkerk CMJ, Taubert R, Jaeckel E, Manns MP, Papp M, Sipeki N, Stickel F, Efe C, Ozaslan E, Purnak T, Nevens F, Kessener DJN, Kahraman A, Wedemeyer H, Hartl J, Schramm C, Lohse AW, Drenth JPH, Heneghan MA. Rapid Response to Treatment of Autoimmune Hepatitis Associated With Remission at 6 and 12 Months. Clin Gastroenterol Hepatol 2020;18:1609-1617.e4. [PMID: 31715274 DOI: 10.1016/j.cgh.2019.11.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
10 Magro F, Drenth JP. Gastroenterological features of COVID-19 and the role of the United European Gastroenterology Journal. United European Gastroenterol J 2020;8:505-6. [PMID: 32450786 DOI: 10.1177/2050640620926832] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Hao J, Sun W, Xu H. Pathogenesis of Concanavalin A induced autoimmune hepatitis in mice. Int Immunopharmacol 2022;102:108411. [PMID: 34891001 DOI: 10.1016/j.intimp.2021.108411] [Reference Citation Analysis]
12 Huang C, Xing X, Xiang X, Fan X, Men R, Ye T, Yang L. MicroRNAs in autoimmune liver diseases: from diagnosis to potential therapeutic targets. Biomed Pharmacother 2020;130:110558. [PMID: 32781357 DOI: 10.1016/j.biopha.2020.110558] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Pape S, Snijders RJ, Gevers TJ, Chazouilleres O, Dalekos GN, Hirschfield GM, Lenzi M, Trauner M, Manns MP, Vierling JM, Montano-loza AJ, Lohse AW, Schramm C, Drenth JP, Heneghan MA, Almasio P, Alvarez F, Andrade R, Arikan C, Assis D, Bardou-jacquet E, Biewenga M, Cancado E, Cazzagon N, Chazouillères O, Colloredo G, Cuarterolo M, Dalekos G, Debray D, Robles-díaz M, Drenth J, Dyson J, Efe C, Engel B, Ferri S, Fontana R, Gatselis N, Gerussi A, Halilbasic E, Halliday N, Heneghan M, Hirschfield G, van Hoek B, Jørgensen MH, Indolfini G, Iorio R, Jeong S, Jones D, Kelly D, Kerkar N, Lacaille F, Lammert C, Leggett B, Lenzi M, Levy C, Liberal R, Lleo A, Lohse A, Lopez SI, de Martin E, Mclin V, Mieli-vergani G, Milkiewicz P, Mohan N, Muratori L, Nebbia G, van Nieuwkerk C, Oo Y, Ortega A, Páres A, Pop T, Pratt D, Purnak T, Ranucci G, Rushbrook S, Schramm C, Stättermayer A, Swain M, Tanaka A, Taubert R, Terrabuio D, Terziroli B, Trauner M, Valentino P, van den Brand F, Villamil A, Wahlin S, Ytting H, Zachou K, Zeniya M. Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group. Journal of Hepatology 2022. [DOI: 10.1016/j.jhep.2021.12.041] [Reference Citation Analysis]
14 Suciu A, Abenavoli L, Pellicano R, Luzza F, Dumitrascu DL. Transaminases: oldies but goldies. A narrative review. Minerva Gastroenterol Dietol 2020;66:246-51. [PMID: 31994373 DOI: 10.23736/S1121-421X.20.02660-4] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Wu R, Liu Y, Yan R, Liu X, Duan L. Assessment of EN-RAGE, sRAGE and EN-RAGE/sRAGE as potential biomarkers in patients with autoimmune hepatitis. J Transl Med 2020;18:384. [PMID: 33036620 DOI: 10.1186/s12967-020-02556-w] [Reference Citation Analysis]
16 Bergan S, Brunet M, Hesselink DA, Johnson-Davis KL, Kunicki PK, Lemaitre F, Marquet P, Molinaro M, Noceti O, Pattanaik S, Pawinski T, Seger C, Shipkova M, Swen JJ, van Gelder T, Venkataramanan R, Wieland E, Woillard JB, Zwart TC, Barten MJ, Budde K, Dieterlen MT, Elens L, Haufroid V, Masuda S, Millan O, Mizuno T, Moes DJAR, Oellerich M, Picard N, Salzmann L, Tönshoff B, van Schaik RHN, Vethe NT, Vinks AA, Wallemacq P, Åsberg A, Langman LJ. Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Ther Drug Monit 2021;43:150-200. [PMID: 33711005 DOI: 10.1097/FTD.0000000000000871] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
17 Pape S, Gevers TJG, Vrolijk JM, van Hoek B, Bouma G, van Nieuwkerk CMJ, Taubert R, Jaeckel E, Manns MP, Papp M, Sipeki N, Stickel F, Efe C, Ozaslan E, Purnak T, Nevens F, Kessener DJN, Kahraman A, Wedemeyer H, Hartl J, Schramm C, Lohse AW, Heneghan MA, Drenth JPH. High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation. Liver Int 2020;40:2164-71. [PMID: 32410363 DOI: 10.1111/liv.14513] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]